Assembly Biosciences ASMB Return on invested capital

Return on invested capital at other companies

Arrowhead ResearchARWR

-38.8%+135pp

Avalo TherapeuticsAVTX

-42.9%—

Arbutus Biopharma CorporationABUS

111.6%+71.5pp

Vir Biotechnology, Inc.VIR

-36.6%-10.5pp

Absci CorporationABSI

-80.3%+11.1pp

Gilead SciencesGILD

-6.7%-24.7pp

FAQ

What is Assembly Biosciences's return on invested capital?

Assembly Biosciences (ASMB) reported return on invested capital of -396.2% in Q1 2025.

How has Assembly Biosciences's return on invested capital changed year-over-year?

Assembly Biosciences's return on invested capital decreased by 60.7% year-over-year, from -246.6% to -396.2%.

What is the long-term trend for Assembly Biosciences's return on invested capital?

Over 3 years (2020 to 2023), Assembly Biosciences's return on invested capital has grown at a 95.6% compound annual growth rate (CAGR), from -30.1% to -225.6%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.